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Factor inhibiting HIF-1a (FIH) is an asparaginyl
hydroxylase. Hydroxylation of HIF-a proteins by FIH
blocks association of HIFs with the transcriptional
coactivators CBP/p300, thus inhibiting transcrip-
tional activation. We have created mice with a null
mutation in the FIH gene and found that it has little
or no discernable role in mice in altering classical
aspects of HIF function, e.g., angiogenesis, erythro-
poiesis, or development. Rather, it is an essential
regulator of metabolism: mice lacking FIH exhibit
reducedbodyweight, elevatedmetabolic rate, hyper-
ventilation, and improved glucose and lipid homeo-
stasis and are resistant to high-fat-diet-induced
weight gain and hepatic steatosis. Neuron-specific
loss of FIH phenocopied some of themajormetabolic
phenotypes of the global null animals: those mice
have reduced body weight, increased metabolic
rate, and enhanced insulin sensitivity and are also
protected against high-fat-diet-induced weight gain.
These results demonstrate that FIH acts to a signifi-
cant degree through the nervous system to regulate
metabolism.
INTRODUCTION
Metabolic response is the act of balancing demand against
substrate availability. A key element of this balance is oxygen
availability, which influences both the rate and the mechanism
of substrate utilization for energy production (Semenza, 2007).
The hypoxia-inducible factors act as regulators of transcriptional
response to low oxygen. They respond to a wide range of
oxygen concentrations and coordinate response via alterations
in expression of at least 300 genes (Weidemann and Johnson,
2008).
The HIF response has a series of complex controls. Central is
enzymatic, oxygen-dependent modification of the HIF-1a and
HIF-2a proteins (Semenza, 2004). This depends on availability364 Cell Metabolism 11, 364–378, May 5, 2010 ª2010 Elsevier Inc.of oxygen for catalysis of two different modifications of HIF-
a proteins. The first oxygen-dependent covalent changes
involve prolyl hydroxylases, or PHDs. These hydroxylate highly
conserved prolines in HIF-a transcription factors; this regulates
ubiquitination and destruction of HIF-a proteins (Semenza,
2007). The second category requires a factor termed FIH
(encoded by the Hif1an gene); this catalyzes asparagine hydrox-
ylation, which blocks association of HIF-a transcription factors
with CBP/p300 transcriptional coactivators (Lando et al., 2002;
Mahon et al., 2001). Null mutations in the PHDs and in the von
Hippel-Lindau tumor suppressor gene (VHL) that mediates
HIF-a ubiquitination all generally exhibit some of the archetypal
features of increased HIF activation, e.g., increased vasculariza-
tion and high levels of erythropoiesis (Aragone´s et al., 2008;
Bishop et al., 2008; Gnarra et al., 1997; Takeda et al., 2006,
2008).
The FIH gene has been associated with hydroxylation events
in a range of other substrates as well, including those in
the Notch pathway (Coleman et al., 2007; Zheng et al., 2008)
and the tankyrase protein (Cockman et al., 2009); given this,
a genetic examination of the role of the FIH gene is essential to
begin a determination of its actual role in animal physiology.
We have found that loss of FIH results in a wide-ranging
derangement of physiological response and causes a hypermet-
abolic phenotype, but results in few of the classical effects of HIF
activation in vivo. These data indicate that inhibition of this
enzyme could provide a unique mechanism for manipulation of
metabolism.RESULTS
Targeting of the FIH Gene Creates a Null Allele
As can be seen in Figure 1A, the FIH gene product is expressed
in a wide range of tissues. We created a conditional null mutation
of the gene, as shown in Figure 1B, with a targeting efficiency
of 2 clones generated for approximately 1800 ES cell clones
screened (Figure S1A). Both isolated clones were able to pro-
duce germline transmission of the altered allele. Mutant animals
were crossed with the EIIa-Cre transgenic line to generate
complete nullizygous alleles (FIHD2) and conditional alleles
(FIHflox), as shown in (d) and (e) of Figure 1B (Lakso et al., 1996).
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Figure 1. Generation of FIH Knockout Mice
(A) Immunoblotting for FIH in adult mouse tissues. Various organs from a 2-month-old wild-type female were harvested and frozen at80C before lysis. Whole-
cell extracts were obtained and immunoblotted for FIH. Hsp90 was used for the loading control.
(B) Strategy of targeting the FIH gene. The genomic wild-type FIH locus around exons 1–4 (filled boxes) is shown (a). A neo cassette (open box) and a loxP site
(filled triangle) from the targeting vector (b) were introduced upstream and downstream of exon 2 by homologous recombination (c), respectively. Restriction sites
(SpeI) and positions of outer and internal probes for Southern blotting are indicated. After Cre-mediated excision, the FIH total knockout (KO) allele (FIHD2) (d) and
the FIH floxed allele (FIHflox) (e) were obtained. PCR primers used for genotyping (p1, p2, p3) are indicated (arrows).
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FIH Regulates MetabolismCrosses of FIHD2 heterozygous animals resulted in animals
homozygous for the FIH null allele, which were verified for loss
of protein (Figure 1C). Genotypes were also confirmed by PCR
analysis (Figure S1B).
The FIH gene encodes an asparaginyl hydroxylase that acts on
the C-terminal activation domain (C-TAD) of HIF-a proteins
(Lando et al., 2002). To determine whether deletion of the FIH
gene results in elimination of hydroxylation of the C-TAD of the
HIF-a proteins, a cloned and tagged C-TAD was stably trans-
fected into MEFs generated from FIHdf embryos (exon2 of the
FIH gene is flanked by two loxP sites). These cells were then
treated with a Cre recombinase expression construct-containing
adenovirus, and control and FIH null cells were created from
untreated and treated cells, respectively. Mass spectrometric
analysis of the C-TAD region, as seen in Figure 1D, showed
that loss of FIH completely eliminated detectable hydroxylation
of the asparagine residue within the C-TAD.
Transcriptional Activation of HIF Target Genes via
C-TAD Is Controlled by FIH
Gene expression assays indicated that loss of FIH in MEFs
caused modest increases in transcription from an HRE reporter
in both normoxic and hypoxic conditions (Figure 1E). Expression
driven by a Gal-HIF-1a-C-TAD construct, where expression is
dependent on C-TAD activity, shows that loss of FIH eliminates
differences in hypoxic versus normoxic expression (Figure 1F).
This occurs through a mechanism dependent on an intact
asparagine at residue 803 in the C-TAD, as mutation of this
residue makes the construct insensitive to the absence of FIH
(Figure 1F).
Gene Expression Analysis Demonstrates a Selective
Clamp Function for FIH
Gene expression levels for a number of genes were surveyed,
but effects on HIF target genes were modest in cells nullizygous
for FIH (Figure 2A). The HIF target genes vascular endothelial
growth factor (Vegf), phosphoglycerate kinase (Pgk), and glucose
transporter-1 (Glut-1) were all minimally affected (Figure 2A).
As can be seen in Figure 2B, loss of the FIH gene results in
a small decrease in cell growth. To determine the effect of the
two factors together on this process, we crossed animals
carrying the conditional allele of the VHL gene (VHLdf) (Haase
et al., 2001) and animals carrying the conditional allele of the
FIH gene (FIHdf) and then derived MEFs (as described above)
from resultant embryos with conditional alleles (VHLdf/FIHdf) of
both the VHL and FIH genes. Figure 2C documents that overall
effects on HIF-1a levels are as expected, with an increase in
HIF-1a levels primarily determined by VHL.
Figures 2D and 2E show the effects on gene expression in
normoxia of loss of the two factors, VHL and FIH, concurrently,
and demonstrate that their deletion has at least two classes of
outcome. The first, seen in the HIF target gene Vegf, is an(C) Immunoblot analysis of E12.5 whole-embryo lysates of wild-type (WT), hetero
(D) MALDI-TOF MS spectra of asparaginyl hydroxylation on HIF-1a in immortaliz
(E) Luciferase assay using HRE (hypoxia response element) reporter in immortali
Luciferase activity was measured 24 hr following transfection.
(F) Luciferase assay using Gal-HIF-1a-C-TAD reporter in immortalized WT and FI
C-TAD. N803A is the mutant form in which asparagine 803 is mutated. Values in
366 Cell Metabolism 11, 364–378, May 5, 2010 ª2010 Elsevier Inc.approximately additive effect (Figure 2D). The second is seen
in a group of genes (Table S1) that includes the carbonic anhy-
drase 9 gene (Car9); here, loss of either VHL or FIH alone creates
a small increase in gene expression, but loss of the two in
tandem causes an approximate 200-fold increase in Car9
expression (Figure 2E). Figures 2F and 2G demonstrate that in
the case of both the Vegf and Car9 genes, a triple deletion of
VHL, FIH, and HIF-1a restores to wild-type levels increased
gene expression caused by loss of VHL and FIH. A gene expres-
sion matrix analysis was carried out, and the effects are shown
graphically in Figure 2H.
As shown in Figure 2I, loss of VHL has a deleterious effect on
cell growth; loss of both factors has an additive negative effect.
The additional loss of HIF-1a (creating VHL/FIH/HIF-1a triple null
cells) restores plating efficiency to wild-type levels and indicates
that overactivation of HIF-1a causes cell death in these experi-
ments.
Loss of FIH Causes an Increase in Cellular ATP Levels
and Suppresses AMPK Activation
To investigate cellular metabolism, we carried out assays on
intracellular ATP levels in wild-type and mutant cells maintained
at normoxia and normoglycemia. In Figure 3A, loss of FIH causes
an increase in cellular ATP levels; this is suppressed in FIH/
HIF-1adouble null cells (FigureS2A). Total levels ofAMPKprotein
aswell as levels of activated AMPKwere determined in normal as
well as hypoxic and hypoglycemic cultures (Figures 3B and S2B)
and showed that loss of FIH suppresses AMPK activation under
hypoglycemic conditions. This suppression is diminished in FIH/
HIF-1a double null cells (Figure S2B). Midgestation FIH null
embryos also had suppressed AMPK activation (Figure 3C);
this indicates an altered metabolic state in development.
Loss of FIH Causes a Hypermetabolic State In Vivo
Activation of HIF in animals can increase glycolysis and reduce
oxygen consumption and thus elevate the respiratory exchange
ratio (RER = VCO2/VO2), a metabolic parameter related to
carbohydrate utilization (an RER that approaches 1.0 is indica-
tive of a predominant use of carbohydrates for fuel). Although
FIH mutant mice have an elevated consumption of oxygen and
increased evolution of carbon dioxide under normoxic condi-
tions (Figures 3D and 3E), RER is not changed in thesemice, indi-
cating glycolysis has not increased relative to wild-type controls
(Figure 3F).
As expected from elevations in oxygen consumption, loss of
FIH causes an approximate 20% increase in heat production
as expressed in calories/hr/unit body mass (Figure 3G). This is
accompanied by an increased mutant heart rate (Figure 3H).
Increased oxygen consumption could be caused by changes
in uncoupled mitochondrial respiration. We examined the
expression levels of mitochondrial uncoupling genes in brown
adipose tissue (BAT), white adipose tissue (WAT), and skeletalzygous (Het), and KO using FIH and tubulin antibodies.
ed WT and FIH null MEFs under normoxia (21% O2).
zed WT and FIH null MEFs under normoxia and hypoxia (1% O2) (n = 3/each).
H null MEFs under normoxia and hypoxia. WT is the wild-type form of HIF-1a-
graphs are expressed as mean ±SEM. See also Figure S1.
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FIH Regulates Metabolismmuscle (SM) and found that the uncoupling protein 1 (UCP1)
mRNA level in BAT from FIH nullizygous mice was significantly
increased (Figure 3I). Levels of peroxisome proliferator-activated
receptor g (PPARg) coactivator-1a (PGC-1a) mRNA were also
increased in BAT from mutant animals (Figure 3J); PGC-1a is
an important regulator of thermogenesis (Uldry et al., 2006).
Expression levels of the uncoupling protein 2 (UCP2) and
uncoupling protein 3 (UCP3) genes in BAT, WAT, and SM and
the PGC-1a gene in WAT were similar between genotypes
(Figures 3I and S3A–S3C).
Mice Lacking FIH Are Hyperventilatory
and Exhibit Alkalosis
Ventilation is strongly affected by hypoxia inmammals; both tidal
volume and respiratory frequency increase as oxygen levels
drop (Huey et al., 2000). To investigate a potential role for FIH
in hypoxic ventilation, we undertook plethysmography of the
mutants (Figures 4A–4C). These analyses demonstrated that
the frequency of breathing at normoxia is not elevated in FIH
mutants (Figure 4A), but that the tidal volume is higher, with
a mean increase of close to 30% (Figure 4B).
The tidal volume (Figure 4B) seen in wild-type mice at hypoxia
is similar to that at normoxia in FIH mutants. Hyperoxia reduces
mutant tidal volume: at 30% oxygen, FIH nullizygous tidal
volumes are not significantly different from those of wild-type
mice. This indicates that FIH may act to regulate the set point
for oxygen-regulated changes in tidal volume.
The elevation in frequency of respiration relative to wild-type
animals is significant only during hypoxia (Figure 4A); this
indicates that a second level of compensation for hypoxia is
triggered in FIH mutant animals; these mutants presumably
have little capacity to increase tidal volume further and thus
respond to decreased oxygenation with an increased respiratory
frequency. This increase in respiratory frequency, in the pres-
ence of an increased tidal volume, could generate increased
levels of blood oxygenation relative to wild-type animals.
Evidence of hyperoxygenation at normoxia is seen in Table S2,
where both pO2 (partial pressure of oxygen) and SO2 (oxygen
saturation) are elevated in arterial blood gas analysis of mutants.
Analysis of minute volume (Vi, in Figure 4C), which is
a measurement of total inspired air over time and thus reflects
both tidal volume and frequency of respiration, shows that the
greatest discrepancy between wild-type and mutant mice is at
normoxia (Figure 4C). At hyperoxia, the genotypic differential in
Vi is no longer statistically significant.Figure 2. Synergistic Effects of FIH and VHL on Regulating HIF Activity
(A) Representative quantitative PCR (qPCR) analysis of mRNA levels for Vegf, Pgk
and hypoxia for 16 hr. Results were normalized to b-actin.
(B) Growth of WT and FIH null MEFs was examined under normoxia and hypoxia. C
and harvested for cell counts every 24 hr. The average cell number of triplicates
(C) Immunoblotting for HIF-1a, FIH, and VHL from whole-cell lysates of immortal
under normoxia or hypoxia for 16 hr before harvest. Tubulin was used as the loa
(D and E) Representative qPCR analysis of mRNA level for Vegf (D) and Car9 (E)
(F and G) mRNA levels of both Vegf (F) and Car9 (G) were restored by a triple de
Primers specific for b-actin were used for normalization.
(H) Venn diagram showing the numbers of up- and downregulated genes in MEF
(I) VHL and FIH have synergistic effects on regulating cell growth. They were rest
under normoxia or hypoxia for 48 hr. Cell numbers of each nullizygous MEF were
graphs are expressed as mean ±SEM; p values are from Student’s t test. See al
368 Cell Metabolism 11, 364–378, May 5, 2010 ª2010 Elsevier Inc.Increased ventilation can be due to hyperpnoea or respiratory
adaptation to an increasedmetabolic rate; this would be accom-
panied by a plasma acidosis or, if compensated, a normal blood
pH. If hyperventilation is occurring, however, the increased
exhalation of carbon dioxide in the absence of a metabolically
driven production of CO2 causes a drop in pCO2 (partial pressure
of carbon dioxide) and an accompanying alkalosis. FIH null
mutants have a clear hypocapnia (decreased pCO2) and respira-
tory alkalosis (increased blood pH), characteristic of hyperventi-
lation (Table S2).
Mice Lacking FIH Have Decreased EPO
Levels in Response to Hypoxia
To further determine how hypoxic physiology is regulated by the
FIH enzyme, we undertook examination of a basal response to
hypoxia: increased expression of the erythropoietic hormone
erythropoietin (EPO) (Semenza, 2009). Consistent with a lack
of HIF-related changes in vascularization in the FIH null mutants
(Figure S4C), basal levels of EPO, hematocrits, and reticulocyte
counts are not different from those of wild-type animals (data not
shown). This also differs from a wide range of tissue-specific
deletions of both the PHDs and VHL, which exhibit increased
EPO expression and varying degrees of polycythemia (Boutin
et al., 2008; Haase et al., 2001; Peyssonnaux et al., 2007; Rankin
et al., 2007; Takeda et al., 2008).
We found that global loss of FIH does alter EPO expression
after 14 hr of exposure to hypoxia (9% O2); levels of plasma
EPO in FIH null animals are reduced by approximately 40%
(Figure 4D). Renal expression of EPO mRNA correlates with
the reduction in plasma EPO levels and is reduced by approxi-
mately 75% relative to wild-type levels posthypoxia (Figure 4E).
To determine whether this was caused by a direct effect on
gene expression, we examined an EPO-expressing cell line,
the Hep3B cell line (Figure 4F). Suppression of FIH by siRNA in
these cells did not, however, alter hypoxic induction of EPO
expression significantly (Figure 4F).
To determine whether loss of EPO inducibility in mutants
occurs in other contexts, we assayed plasma EPO levels
following induction of experimental anemia (Figure 4G). This
assay employs phenylhydrazine (PHZ) to induce red blood cell
lysis; following treatment, hematocrits in experimental animals
drop, and the resulting anemia causes an increase in EPO
expression. In these experiments, there were no significant
changes in plasma EPO levels in mutants relative to wild-type
animals (Figure 4G) and no alteration in induction of renal EPOIn Vitro
, and Glut-1. Immortalized WT and FIH null MEFs were treated under normoxia
ells seeded at a low density were incubated in normoxic or hypoxic conditions
for each condition is shown.
ized WT, FIH null, VHL null, and VHL/FIH double null MEFs. Cells were treated
ding control.
in WT, VHL null, and VHL/FIH null MEFs (n = 3/genotype).
letion of VHL, FIH, and HIF-1a. For (D–F), cells were cultured under normoxia.
s using a filter ofR2-fold change.
ored by deletion of HIF-1a. MEFs were seeded at a low density and incubated
counted and normalized to relative wild-type MEFs (n = 3/condition). Values in
so Table S1.
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Figure 3. Hypermetabolism in FIH KO Mice
(A) Intracellular ATP levels in primary WT and FIH null MEFs under normoxia (n = 3/group).
(B) Levels of phospho-AMPK and total AMPK were measured by immunoblotting with whole-cell lysates from primary WT and FIH null MEFs treated with condi-
tions as indicated.
(C) Immunoblotting analysis of whole-cell lysates from E12.5 WT (n = 3), FIH Het (n = 5), and FIH KO (n = 5) embryos using phospho-AMPK, total AMPK, FIH, and
tubulin antibodies.
Cell Metabolism
FIH Regulates Metabolism
Cell Metabolism 11, 364–378, May 5, 2010 ª2010 Elsevier Inc. 369
Cell Metabolism
FIH Regulates Metabolismexpression (Figure 4H). This demonstrates that the alteration in
EPO expression that we see in FIH mutants is not related to
direct effects on EPO expression in EPO-synthesizing tissues,
but is correlated with altered respiration during hypoxia.
Loss of FIH Causes Decreased Body Mass and Adiposity
Loss of FIH causes an increase in both food andwater consump-
tion in conjunction with the increased metabolic rate described
above (Figures 5A and 5B). Physical activity is a central aspect
of energy expenditure and so was measured together with O2
consumption. As shown in Figure 5C, a significantly higher O2
consumption in mutants accompanied a surprising hypoactivity,
especially during dark cycles.
Body weight represents to some extent a balance between
energy intake and expenditure. Overall body mass in FIH nullizy-
gous mice is lower at birth (Figure 5D) and throughout life
(Figure 5E). This is accompanied by a decrease in epididymal
WAT (Figure 5F and Table S4). Adipocytes from FIH nullizygous
mice are significantly smaller than those from control mice
(Figures 5G–5I), demonstrating decreased adiposity.
To determine the effect of FIH deletion on glucose physiology,
glucose and insulin tolerance tests (GTTs and ITTs) were carried
out (Figures 5J and 5K). Loss of FIH had little effect on glucose
clearance, but had a significant effect on insulin sensitivity (Fig-
ure 5K). Correlated with an enhanced insulin sensitivity was
a significantly lower fed plasma insulin level inmutants (Figure 5L)
and improved lipid homeostasis. Serum triglyceride (TG), high-
density lipoprotein (HDL) cholesterol, low-density lipoprotein
(LDL) cholesterol, very-low-density lipoprotein (VLDL) choles-
terol, and total serum cholesterol levels were all significantly
lower in mutant animals (Table S3).
Tissue-Specific Loss of FIH Indicates that
Hypermetabolism Is Neuronally Regulated
under Normal Chow
We found that FIH is expressed at similar levels in different brain
regions, i.e., cortex, hypothalamus, and brain stem (Figure S5A).
Animals were created with a pan-neuronal loss of FIH by
crossing into a background of nestin promoter-driven Cre
expression. Specific deletion of FIH was confirmed by immuno-
blotting and quantitative PCR (Figures 6A and S5B). These
tissue-specific deletion mutants are significantly smaller than
controls (Figure 6B) and phenocopy the increased metabolic
rate seen in global FIH null animals (Figure 6C).
To investigate whether loss of FIH in neurons affects glucose
homeostasis, GTTs and ITTs were performed: neuronal FIH
null mutants exhibited improved insulin sensitivity, although
glucose tolerance was unchanged (Figures 6D and 6E). There
was no significant difference in fasting blood glucose levels in(D) Resting whole-body O2 consumption (VO2) in 2-month-old WT (n = 7) and FIH
(E) Resting CO2 production (VCO2) in the same mice as in (D).
(F) RER (respiratory exchange ratio) was determined during the same period as i
(G) Heat production was determined during the same measurement as in (D).
(H) Heart rates were measured in resting 2-month-old WT (n = 9) and FIH KO (n
(I) UCP1, UCP2, and UCP3 mRNA levels in brown adipose tissue (BAT) from 5-m
(J) PGC-1amRNA levels in BAT from 5-month-old mice under normal chow were m
specific primers for b-actin were used for normalization. Values shown in graph
Figures S2 and S3.
370 Cell Metabolism 11, 364–378, May 5, 2010 ª2010 Elsevier Inc.2-month-old animals (Figure S5C), but fasting plasma insulin
levels in mutants were lower (Figure S5D), which correlates
with an enhanced insulin sensitivity.
In contrast, hepatic loss of FIH in an albumin-Cre background
had no effect on overall body weight and metabolic rate (Figures
S6A–S6C); loss of FIH in liver did not affect glucose homeostasis
(Figures S6D–S6F).
Expression of HIF-1a target genes, including Pgk, Vegf,
Glut-1, Bnip3, andCar9, is not significantly elevated in the brains
of FIH nullizygous mice (Figure S5E). This indicates that the
neuronal FIH mutant phenotype is not directly related to a large
and tissue-specific alteration in gene expression of HIF target
genes in the central nervous system.
FIH Knockout Mice Are Protected from High-Fat-Diet-
Induced Weight Gain and Hepatic Steatosis
Todeterminewhether global deletion of FIH influences theweight
gain, insulin resistance, and hepatic steatosis seen when mice
are administered a high-fat diet (HFD), we fed FIH null mice and
wild-type littermates for 4 months with a 60% fat diet. As can
be seen in Figures 7A and S7A, this caused weight gain in both
wild-type and mutant mice; however, mutants gained signifi-
cantly lessweight relative towild-type animals. This divergence is
not seenover timewhenanimals are fed normal chow (Figure 7B).
We next measured individual tissue weights of liver, epidid-
ymal WAT, quadriceps, and kidney, and found that under
a HFD there were significant changes in tissue/body mass ratios
of liver and quadriceps in mutants relative to wild-type animals
(Table S4B). FIH global deletion mice also have higher metabolic
rates under HFD (Figure 7C) and no difference in GTTs (Figures
7D and S7C), but ITTs show that mutants maintain increased
insulin sensitivity (Figures 7E and S7D). This is correlated with
lower fasting glucose levels (Figure 7F) and fed insulin levels in
mutants (Figure 7G). Although HFD increased serum cholesterol
levels, FIH null mutants still showed significantly lower serum
LDL/VLDL levels (Table S3).
HFD can lead to hepatic steatosis or fatty liver. Overall liver/
body mass ratio was significantly decreased in FIH nullizygous
mice (Figures 7I and S7B). Liver sections show that loss of FIH
causes a decrease in lipid droplets (Figure 7J); quantification
demonstrated that hepatic TG content of FIH nullizygous mice
was reduced by 60% (Figure 7K).
Reduced lipogenesis and increased b-oxidation are possible
causes of reduced steatosis: we found no changes in mRNA
levels of b-oxidation enzymes, but decreases in lipogenic
enzymes (e.g., Scd1). Interestingly,wealsodetected significantly
lower hepatic PPARg expression in FIH nullizygous livers from
HFD-fed mice (Figure 7L); this is the opposite of the trend in
PPARg expression in WAT (Figure 7H) and indicates thatKO (n = 5) mice. Shown are the average values over 3 hr.
n (D).
= 5) mice under normoxic condition.
onth-old mice under normal chow were measured by qPCR (n = 6/genotype).
easured by qPCR (n = 6/genotype). For gene expression analysis in (I) and (J),
s are expressed as mean ±SEM; p values are from Student’s t test. See also
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Figure 4. FIH KO Mice Are Hyperventilatory
(A) Respiration frequencies of unrestrained WT (n = 7) and FIH KO (n = 8) mice under acute hypoxia (10% O2), room air (21% O2), and hyperoxia (30% O2) were
measured using barometric pressure plethysmography.
(B) Tidal volume (Vt) was measured in the same assay as in (A).
(C) Inspired minute ventilation (Vi) was determined in the same assay as in (A).
(D) Plasma EPO levels in WT and FIH KO mice following acute hypoxic exposure at 9% O2 for 14 hr (n = 15/genotype).
(E) Analysis of renal EPO mRNA levels in hypoxia-treated WT (n = 7) and FIH KO (n = 8) mice (9% O2, 14 hr) by qPCR. Kidneys were collected immediately after
hypoxia treatment, fast frozen in liquid N2, and stored at 80C before RNA isolation.
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FIH Regulates Metabolismmetabolic changes in PPARg expression may help explain how
FIH loss inhibits HFD-induced hepatic steatosis.
Finally, to examine whether a tissue-specific deletion of FIH in
neurons also protects mutants from HFD-induced weight gain,
we fed 4-week-old FIH neuronal knockout (NKO) mice and
wild-type littermates HFD for 10 weeks. At 8 week and 10
week time points, FIH NKOmice fed with HFD had gained signif-
icantly less weight (Figures 7M and 7N), consistent with a role for
neuronal FIH expression in regulating HFD-induced weight gain.
DISCUSSION
Together, these data indicate that FIH, the asparaginyl hydroxy-
lase, exerts a wide-ranging control over metabolism. This is
surprising from many perspectives, particularly in reference to
phenotypes of other mutations in the HIF pathway. Global and
conditional mutations of genes regulating HIF are generally dele-
terious, causing embryonic lethality or significant changes in
vascularization or erythropoiesis. The data presented here
demonstrate that the two hydroxylase-regulated HIF control
pathways play very different roles in vivo.
The FIH enzyme has a higher affinity for oxygen than the PHD
enzymes (Koivunen et al., 2004; Peet et al., 2004). Thus, FIH
could suppress HIF at different oxygen concentrations from
those where the PHDs are most active. We find little evidence
for this in vitro, where alterations in gene expression caused by
FIH are for the most part small at both normoxia and hypoxia.
It is clear, however, that some genes, e.g., Car9, are highly
dependent on FIH control when VHL is absent; it is intriguing
to speculate that further investigation of genes that show a
requirement for both elements of hydroxylase control may unveil
a functional relationship among such targets.
We have found that cellular metabolism is altered by deletion
of FIH. Curiously, this alteration in metabolism, with an increase
in intracellular ATP levels in MEFs and a repression of AMP
kinase activation in developing embryos, is not accompanied
by the acidosis and increased glycolysis thought to typify
increased HIF activation in animals. Analysis of whole-body
energy expenditure demonstrated that there is an acceleration
of metabolic rate in FIH mutants, but there is no evidence of
increases in glycolysis. Thus, the altered metabolism of these
mutants is not simply a change in HIF activation leading to
increases in glycolysis and suppression of oxidativemetabolism.
UCP1 andPGC-1a expression in BATwere significantly elevated
in FIH KO mice, indicating increased energy expenditure in FIH
KO mice may be due to increased thermogenesis in BAT.
Deletion of PHD1 in mice results in reduced O2 consumption
by attenuating glucose oxidation; this was dependent on HIF
function (Aragone´s et al., 2008, 2009). As discussed above,
different affinities of PHD1 and FIH for oxygen may represent
a possible explanation for why they exhibit differential effects
on energy expenditure, but further investigation is needed to
understand this phenomenon.(F) Representative qPCR analysis of mRNA levels for EPO in Hep3B cells follow
hypoxic conditions for 16 hr before harvest (n = 3/condition).
(G) Plasma EPO levels in WT (n = 6) and FIH KO (n = 5) mice after overnight PHZ
(H) qPCR analysis of renal EPO expression in PHZ-treatedmice (same as those inG
are expressed as mean ±SEM; p values are from Student’s t test. See also Table
372 Cell Metabolism 11, 364–378, May 5, 2010 ª2010 Elsevier Inc.Our data also connect the function of the FIH oxygen sensor
with glucose and lipid metabolism in vivo. We have found that
FIH null animals are smaller in size and weigh less when fed
normal chow. They exhibit increased insulin sensitivity, which
is correlated with significantly decreased plasma insulin levels.
In contrast, there is no difference in glucose tolerance. FIH null
mutants also show improved lipid homeostasis, with large
reductions in serum TG and cholesterol levels. Mice with
tissue-specific deletions of FIH demonstrate that deletion of
FIH in neurons also leads to decreased body weight, increased
energy expenditure, and improved insulin sensitivity and thus
phenocopy global FIH null animals. Hepatic deletion animals
did not have any of these metabolic phenotypes, arguing for
a predominant role for FIH in the nervous system; clearly, further
investigation of this is needed to isolate neuronal FIH-regulated
pathways of metabolic control.
Deletion of FIH protects against HFD-induced weight gain and
hepatic steatosis. The former may be explained by increased
energy expenditure and improved insulin sensitivity in FIH global
null animals. The latter is correlated with decreased expression
of lipogenic genes in liver and increased adiponectin expression
in WAT. Interestingly, FIH neuronal null mice are also protected
against HFD-induced weight gain.
The findings described here indicate a specific role for FIH in
the process of respiratory control: maintenance of a set point
for normoxic respiration. In the absence of FIH, tidal volumes
at normoxia are equivalent to those seen in severely hypoxic
wild-type animals. This increased tidal volume is not constitutive:
when breathing 30% oxygen, FIH mutant mice decrease tidal
volumes to levels not significantly different from those of wild-
type mice. This indicates that loss of FIH has shifted oxygen-
mediated control of respiration to a lower response point.
The regulation of chronic ventilatory adaptation has been
shown to be a function of the HIF pathway in mice heterozygous
for HIF-1a (Kline et al., 2002; Peng et al., 2006). Increased venti-
lation can be related to increases in metabolic rate; these would
typically involve metabolically driven acidosis. In these mice, we
see instead a respiratory alkalosis, which would indicate that
some degree of hyperventilation is occurring. Hyperventilation
could involve defective functioning of the carotid bodies, and
the suppression of the hyperventilatory phenotype by hyperoxia
in these mice could indicate an altered carotid body set point
in the FIH null mice. The nestin gene, whose promoter drives
Cre recombinase expression in our neuronal FIH null mice, is
expressed in carotid bodies (Izal-Azca´rate et al., 2008). Thus,
preservation of the respiratory changes in neuronal FIH deletion
could indicate that carotid body FIH is a key factor in regulating
respiration. Further investigation is underway to determine this in
isolated carotid bodies, with an ultimate goal of defining the
mechanism of signaling controlled by FIH hydroxylation.
As discussed above, our results in global FIH null and neuron-
specific FIH null animals reveal the role of this gene in regulation
of metabolism. A key question is whether this is related toing control or hFIH siRNA treatment. Cells were cultured under normoxic or
treatment.
). Results in (E), (F), and (H) were normalized to b-actin. Values shown in graphs
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FIH Regulates Metabolismregulation of HIF function, or to altered activity of other putative
FIH targets. Loss of VHL in hepatocytes results in a severe HIF-
dependent steatosis, and deletion of HIF-1b in liver results in
increased hepatic gluconeogenesis and lipogenic gene expres-
sion but reduced hepatic lipid storage (Rankin et al., 2009; Wang
et al., 2009). These data indicate that HIF activation increases
steatosis in the liver. However, we see reduction in steatosis
following FIH deletion, which may indicate that the metabolic
changes we are observing are not directly related to increased
HIF activity.
Besides HIF, FIH has been shown to hydroxylate a range of
other substrates in vitro; these includeproteins containingankyrin
repeat domains (ARDs), such as the intracellular domain of Notch
receptors (Coleman et al., 2007; Zheng et al., 2008), p105, IkBa
(Cockman et al., 2006), SOCS (suppression of cytokine signaling)
box protein 4 (ASB4) (Ferguson et al., 2007), MYPT1 (Webb et al.,
2009), Tankyrase-2, Rabankyrin-5, and RNase L (Cockman et al.,
2009). This range of substrates has complicated the determina-
tion of direct FIH action, as the intersecting functional roles
between these hydroxylation events are potentially large. As a
further complication, one postulated role for the association of
FIH with an ARD-containing substrate has been that they act to
sequester FIH from HIF and thus potentiate HIF activation (Cole-
man and Ratcliffe, 2009;Wilkins et al., 2009). Our studies provide
useful genetic mousemodels for further investigating the physio-
logical outcome of FIH hydroxylation on these substrates.
In conclusion, our data clearly show that the oxygen sensor
FIH regulates respiration, energy balance, and lipid metabolism.
They also demonstrate a role for neuronal FIH in regulation of
bodymass, energy expenditure, and insulin sensitivity. Thus, FIH
is a ready target for broad-spectrum pharmacological inhibition
of hydroxylase activation and, in particular, FIH-specific inhibi-
tors (Banerji et al., 2005; Nagel et al., 2010). Our data indicate
that such inhibitors, especially those able to inhibit FIH function
in neurons, might have significant therapeutic potential in
reducing body weight and increasing insulin sensitivity.EXPERIMENTAL PROCEDURES
Generation of FIH KO Mice
The targeting vector was constructed by inserting three fragments of the
FIH gene from murine Sv129 embryonic stem (ES) cells into pFloxDTK (gift of
S. Hedrick). Offspring containing the modified FIH allele were mated with
EIIa-Cre transgenic mice (gift of C. Murre) to generate FIHD2/+ and FIHflox/+Figure 5. Global Loss of FIH Causes Decreased Body Mass, Decrease
(A) Food intake was measured in WT and KO mice (n = 8/genotype) over 3 day/n
(B) Water intake was measured in the same assay as in (A).
(C) Physical activity was measured in the same assay as in (A) and (B). p = 0.005
(D) Body weights of newborn WT and KO mice. n = 17–18 for females and n = 1
(E) FIH KO mice are significantly smaller than their WT littermates. Growth curve
(F) Epididymal white fat pad weight normalized with body weight was measured
(G) Representative images of H&E-stained epididymal WAT sections from 5-mon
100 mm.
(H) Epididymal adipocyte areas were measured from 5-month-old WT and KO m
(I) Counts of adipocytes in different sizes from the same mice used in (H).
(J) Glucose tolerance test (GTT) was measured for 18 hr fasting 2-month-old WT
(K) Insulin tolerance test (ITT) was performed on 4 hr fasting 2-month-old WT and
**p < 0.01.
(L) Fed insulin levels were measured on 5-month-old WT and KOmice. n = 9/geno
Student’s t test (except C). See also Figure S4 and Tables S3 and S4.
374 Cell Metabolism 11, 364–378, May 5, 2010 ª2010 Elsevier Inc.mice. FIHD2/+ mice were bred to obtain FIH KO mice (FIHD2/D2). FIHflox/+
mice were bred to obtain FIHdf mice.
Animal Experiments
All animal experiments were performed according to the animal protocol
approved by the Institutional Animal Care and Use Committee. Albumin-Cre
and Nestin-Cre mice were obtained from Jackson Laboratory.
Immunoblotting
Immunoblotting analysis was performed using antibodies as described in the
Supplemental Experimental Procedures.
Quantitative PCR Analysis of Gene Expression and Gene Deletion
Sequences for the primers and probes of mouse genes used in this study are
found in the Supplemental Experimental Procedures.
Cell Culture
Cells were cultured in DMEM. Mouse embryonic fibroblasts (MEFs) were iso-
lated from E12.5 embryos and immortalized by stable transfection with SV40
large T antigen. FIHdf, VHLdf, VHLdf/FIHdf, VHLdf/FIHdf/HIF-1adf, and FIHdf/
HIF-1adf MEFs were transiently infected with adenovirus expressing b-galac-
tosidase or Cre recombinase to obtain WT and null MEFs.
Measurement of Free ATP in MEFs
Free ATP in primary MEFs was measured using ATP Bioluminescence Assay
Kit CLS II (#11699695001, Roche Diagnostics GmbH; Mannheim, Germany)
in accordance with the protocol provided by the manufacturer.
Transfection and Luciferase Assay
WT and FIH null MEFs were transfected by Lipofectamine 2000 (Invitrogen;
Carlsbad, CA) with pGL3 and pGL3-HRE plasmids. pRSV-b-gal was also
cotransfected into cells for normalization. One day after transfection, cells
were incubated in normoxic or hypoxic conditions for 18 hr.
Mass Spectrometry
Mass spectrometry methods are described in detail in the Supplemental
Experimental Procedures.
Microarray Analysis
Total RNA for microarray analysis was extracted from WT, FIH null, VHL null,
and VHL/FIH null MEFs under normoxic conditions; arrays were GeneChip
Mouse Genome 430 2.0 Array (Affymetrix, Inc.; Santa Clara, CA). Duplicates
were performed for each sample. Venn diagram was generated by using
GeneSpring GX 9.0 software.
Metabolic Cage Studies
Energy expenditure of FIH KOmice and their WT littermates was measured by
using the Columbus Instruments Oxymax System.
Food and water intake and physical activity of mice were measured using
the comprehensive lab animal monitoring system (CLAMS, Columbus Instru-
ments; Columbus, OH).d Adiposity, and Increased Insulin Sensitivity
ight cycles as monitored by CLAMS.
by two-way ANOVA.
1–14 for males, respectively.
s show the average weights of WT (n = 34) and KO (n = 22) males. *p < 0.05.
from 2-month-old and 5-month-old WT and KO male mice. **p < 0.01.
th-old WT and KO mice fed with normal chow (NC). The scale bar represents
ice. n = 3/genotype.
and KO mice fed with NC (2 g D-glucose/kg body weight). n = 10/genotype.
KO mice fed with NC (0.75 U/kg body weight). n = 10–11/genotype. *p < 0.05,
type. Values shown in graphs are expressed as mean ±SEM; p values are from
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Figure 6. Neuron-Specific Loss of FIH Indicates that Hypermetabolism Is Neuronally Regulated under Normal Chow
(A) Immunoblot analysis of whole-cell lysates of brain and liver samples from FIH neuron-specific knockout mice (FIH NKO) and WT mice using FIH and tubulin
antibodies. The upper bands in brain samples are nonspecific.
(B) Growth curves of FIH NKO (n = 17) and their WT (n = 15) littermates under normal chow. ***p < 0.001.
(C) Resting whole-body VO2, VCO2, RER, and heat production in 2-month-old WT (n = 7) and FIH NKO (n = 5) mice. Shown are the average values over 3 hr.
(D) GTTs were measured for 18 hr fasting 2-month-old WT (n = 6) and FIH NKO (n = 6) mice (2 g D-glucose/kg body weight).
(E) ITTs were performed on 4 hr fasting 2-month-oldWT (n = 7) and FIH NKO (n = 6) mice (0.75 U/kg body weight). *p < 0.05, **p < 0.01. Values shown in graphs are
expressed as mean ±SEM; p values are from Student’s t test. See also Figures S5 and S6.
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FIH Regulates MetabolismHypoxia Exposure
For acute hypoxia exposure, age-matched FIH KO mice and their wild-type
littermates were exposed to 9% O2 for 14 hr in hypoxia chamber (Biospherix;
Lacona, NY).
PHZ-Induced Anemia
PHZ (60 mg/kg body weight, Sigma-Aldrich; St. Louis) dissolved in sterile
phosphate-buffered saline was injected intraperitoneally into 2-month-old
mice to induce hemolysis. Eighteen hours after administration, tissue and
plasma samples were collected for analysis.CEPO ELISA
Plasma EPO levels were determined by using the Mouse EPO ELISA kit (R&D
Systems; Minneapolis, MN).
Ventilation Measurement
Ventilation was measured in unrestrained 2-month-old mice using barometric
pressure plethysmography as described previously for rats (Reid and Powell,
2005), with modifications to the chamber volumes and flows appropriate for
mice and a new analog-digital recording system and custom Matlab analysis
routine.ell Metabolism 11, 364–378, May 5, 2010 ª2010 Elsevier Inc. 375
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Cell Metabolism
FIH Regulates MetabolismMeasurement of Mouse Heart Rate
According to manufacturer’s protocol, the measurement was done using
MouseOx Pulse Oximeter with CollarClip Sensor (STARR Life Sciences
Corp.; Oakmont, PA).
High-Fat Feeding
In high-fat feeding experiments, 1-month-old males were fed with HFD (60%
fat content, Research Diets, Inc.; New Brunswick, NJ). Body weights were
measured weekly.
Metabolic Measurements
Measurement methods for blood metabolic markers are described in the
Supplemental Experimental Procedures.
Histology
Paraffin-embedded tissue sections were stained with hematoxylin and
eosin (H&E) using a standard protocol. For oil red O staining, it was performed
on frozen liver sections by UCSD histology core according to the standard
procedure.
Quantification of adipocyte area was done on H&E-stained sections using
ImageTool software.
Statistics
Values in the figures are expressed as mean ±SEM. Student’s t test (unpaired,
two-tailed) and two-way ANOVA were used for statistical analysis.
ACCESSION NUMBERS
Microarray data are deposited at NCBI GEO (accession number GSE20335).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, seven figures, and four tables and can be found
with this article online at doi:10.1016/j.cmet.2010.03.001.
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Published online: April 15, 2010Figure 7. FIH KO Mice Are Protected from High-Fat-Diet-Induced Weig
(A) Accumulated weight gain of WT and KO mice fed with high-fat diet (HFD) for 1
(B) Accumulated weight gain of WT and KO mice fed with NC for 12 weeks. n =
(C) Resting whole-body VO2, VCO2, RER, and heat production in WT (n = 6) and
(D) GTTs were measured for 18 hr fasting WT (n = 9) and KO (n = 7) mice fed wit
(E) ITTs were performed on 4 hr fasting WT (n = 7) and KO (n = 5) mice fed with
(F) Fasting blood glucose levels were measured on 18 hr fasting WT (n = 20) and
(G) Fed insulin levels were measured on WT and KO mice fed with HFD for 16 w
(H) Expression levels of genes encoding PPARg, Adiponectin, and CAP were incr
***p < 0.001.
(I) Liver weight normalized with body weight from WT and KO mice fed with HFD
(J) Top: representative images of H&E-stained liver sections fromWT andKOmice
The scale bar represents 100 mm.
(K) Hepatic triglyceride contents were measured in WT and FIH KO livers under
(L) Expression levels of genes encoding lipogenic enzymes (FAS, Acc1, and Scd1)
of WT and KO mice fed with HFD. n = 6/genotype, *p < 0.05, **p < 0.01. WAT an
(M) Accumulated weight gain of FIH neuronal KO (NKO) mice (n = 6) and their W
(N) Accumulated weight gain of FIH NKO (n = 17) and theirWT littermates (n = 13) fe
p values are from Student’s t test. See also Figure S7 and Tables S3 and S4B.
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